Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.
about
Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational studyDevelopment of an economic evaluation of diagnostic strategies: the case of monogenic diabetesEffects of a Follow-On Formula Containing Isomaltulose (Palatinose™) on Metabolic Response, Acceptance, Tolerance and Safety in Infants: A Randomized-Controlled TrialUrinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.Reclassification of diabetes etiology in a family with multiple diabetes phenotypesAssessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin.Post-glucose-load urinary C-peptide and glucose concentration obtained during OGTT do not affect oral minimal model-based plasma indicesPractical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis.The clinical utility of C-peptide measurement in the care of patients with diabetesSystematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes.The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cellsUrinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion.Urinary C-peptide analysis in an intervention study: experience from the DEFEND-2 otelixizumab trial.The clinical potential of low-level C-peptide secretion.Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors.Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.The effect of insulin resistance on postprandial triglycerides in Korean type 2 diabetic patients.Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase.Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
P2860
Q28660810-867693C2-5F38-4977-A551-266DAD9B0BD3Q28689671-10434A24-1053-4A94-9C47-2031792B810EQ33467472-61AFB2AA-E0F7-45A3-8663-4313BFB76F9AQ34131203-8D2DB853-065F-413E-A738-DC1738188C5AQ34294841-EB646AA3-7BED-4232-BD1B-7EB22BED1832Q34297738-D0D39E7C-6B09-4D97-B353-BF6AB847816BQ36778119-00360944-1897-40C1-B80D-5E5BA27847DEQ36818151-5A527995-C04E-4E96-A620-E186DA6FE939Q37108880-F60D0618-7286-4430-B3F3-3DD2FEAEECAAQ37246676-59F91A97-4365-4D67-99E4-8EA0FDDFF561Q37374229-6F792890-A12F-4922-B107-563CD9F0EEB2Q37576692-D5A5A009-9549-4A7D-ABD1-B576A2F60CD7Q38811287-56F1655E-DB98-464C-B2B2-AC49CCE42941Q38889362-32A1CEA7-89CA-431A-B255-ABDEA366ED13Q39593898-82EDBE11-017B-42F4-9841-6D73810200A3Q41251582-02CFBD01-DECC-4B38-AA7B-AEABA4A5D01BQ42380027-6BACE46D-DEB9-4469-9280-7D58FFC29DAAQ43805190-FA8FB933-1A31-4E67-A847-9AEE865AC72FQ45013586-769F208D-244F-4D73-B0E2-D851D032D04EQ51280338-5A90ACC1-C217-41C0-8D48-D29D29003F20Q51368838-B69E8F0C-CD03-4A11-AF0A-B76BA0F15E6FQ52874770-02447820-4C1A-4D1B-A203-9C7B02405F99Q54580077-D4CE0A58-7E5E-4412-8425-E375B545EB10Q55422993-C6136782-B11A-4043-AF91-2A4F32D3F5FFQ57646454-43A69B1E-E68F-4508-AE68-3FC161F4056B
P2860
Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@ast
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@en
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@nl
type
label
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@ast
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@en
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@nl
prefLabel
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@ast
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@en
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@nl
P2093
P2860
P50
P356
P1433
P1476
Urine C-peptide creatinine rat ...... d adults with type 1 diabetes.
@en
P2093
Beverley M Shields
Bridget A Knight
Rachel E J Besser
P2860
P304
P356
10.2337/DC10-2114
P407
P577
2011-02-01T00:00:00Z